Anti-Cyclin E2 antibody [EP454Y]
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(1 Review)
|
(36 Publications)
Anti-Cyclin E2 antibody [EP454Y] (ab40890) is a rabbit monoclonal antibody detecting Cyclin E2 in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications
- Trusted since 2006
View Alternative Names
G1/S-specific cyclin-E2, CCNE2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin E2 antibody [EP454Y] (AB40890)
ab40890 (unpurified) at 1/250 staining human breast carcinoma by immunohistochemistry, paraffin-embedded tissue.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cyclin E2 antibody [EP454Y] (AB40890)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling Cyclin E2 with purified ab40890 at 1 : 50 dilution (2.8 μg/ml). Cells were fixed in 100% Methanol and permeabilized with None. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin E2 antibody [EP454Y] (AB40890)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma tissue sections labeling Cyclin E2 with purified ab40890 at 1/100 dilution (1.41 µg/ml). Heat mediated antigen retrieval was performed Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Cyclin E2 antibody [EP454Y] (AB40890)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling Cyclin E2 (right) with purified ab40890 at a 1/20 dilution. Cells were fixed with 90% ethanol and permeabilized with 90% methanol. A goat anti-rabbit IgG (Alexa Fluorr® 488) (ab150077) was used as the secondary antibody at a 1/2000 dilution.
Left panel - Rabbit monoclonal IgG (ab172730).
- IP
Unknown
Immunoprecipitation - Anti-Cyclin E2 antibody [EP454Y] (AB40890)
ab40890 (purified) at 1/20 dilution (1 µg) immunoprecipitating Cyclin E2 in Jurkat whole cell lysate.
Lane 1 (input) : Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate 10 µg
Lane 2 (+) : ab40890 & Jurkat whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab40890 in Jurkat whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Cyclin E2 antibody [EP454Y] (ab40890)
Predicted band size: 47 kDa
false
- WB
Lab
Western blot - Anti-Cyclin E2 antibody [EP454Y] (AB40890)
Lanes 1 - 4 : Merged signal (red and green). Green - ab40890 observed at 45 kDa. Red - loading control, ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab40890 was shown to react with CCNE2 in HAP1 wild-type cells in Western blot. Loss of signal was observed when CCNE2 knockout sample was used. HAP1 wild-type and CCNE2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% Milk in TBS-T (0.1% Tween®) before incubation with ab40890 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 10000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Cyclin E2 antibody [EP454Y] (ab40890) at 1/10000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
CCNE2 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
MCF7 whole cell lysate at 20 µg
Lane 4:
HeLa whole cell lysate at 20 µg
Predicted band size: 47 kDa
Observed band size: 45 kDa
false
- WB
Lab
Western blot - Anti-Cyclin E2 antibody [EP454Y] (AB40890)
All lanes:
Western blot - Anti-Cyclin E2 antibody [EP454Y] (ab40890) at 1/1000 dilution
All lanes:
Jurkat (Human T cell leukemia T lymphocyte) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 47 kDa
Observed band size: 45 kDa
false
Related conjugates and formulations (8)
-
Anti-Cyclin E2 antibody [EP454Y] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cyclin E2 antibody [EP454Y]
-
HRP Anti-Cyclin E2 antibody [EP454Y]
-
660 APC
APC Anti-Cyclin E2 antibody [EP454Y]
-
578 PE
PE Anti-Cyclin E2 antibody [EP454Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Cyclin E2 antibody [EP454Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cyclin E2 antibody [EP454Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Cyclin E2 antibody [EP454Y]
Reactivity data
Product details
What is this antibody validated in?
Anti-Cyclin E2 antibody [EP454Y] (ab40890) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.
What is the molecular weight of Cyclin E2?
Anti-Cyclin E2 [EP454Y] (ab40890) specifically detects a band for Cyclin E2 (UniProt: O96020) at a molecular weight of 50kDa.
Trusted by the scientific community
Anti-Cyclin E2 [EP454Y] (ab40890) was first used in a scientific publication in 2006 and has been cited over 20 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-Cyclin E2 antibody [EP454Y] (ab40890) has been confirmed by Western blot testing in Cyclin E2 Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EP454Y] also available for your convenience: ab40890, Alexa Fluor® 488 - ab200423, Alexa Fluor® 647 - ab200424, HRP - ab200425, Carrier free - ab239833, APC - ab319291, PE - ab319438, Alexa Fluor® 594 - ab319784, Alexa Fluor® 555 - ab319925, Alexa Fluor® 750 - ab321628
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (36)
Recent publications for all applications. Explore the full list and refine your search
Cellular oncology (Dordrecht, Netherlands) 48:815-834 PubMed40327295
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 63:1907-1921 PubMed38923703
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology research 32:585-596 PubMed38361755
2024
Applications
Unspecified application
Species
Unspecified reactive species
The journal of gene medicine 26:e3616 PubMed38049938
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:112768 PubMed37428633
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37446141
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 17:1648-1665 PubMed37013960
2023
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 24:e56052 PubMed36896611
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:985827 PubMed36818671
2023
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2023:2826815 PubMed37964983
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com